ATE321041T1 - Alkoxycarbonylamino-heteroaryl- carbonsäurederivate als ip-antagonisten - Google Patents
Alkoxycarbonylamino-heteroaryl- carbonsäurederivate als ip-antagonistenInfo
- Publication number
- ATE321041T1 ATE321041T1 AT02722126T AT02722126T ATE321041T1 AT E321041 T1 ATE321041 T1 AT E321041T1 AT 02722126 T AT02722126 T AT 02722126T AT 02722126 T AT02722126 T AT 02722126T AT E321041 T1 ATE321041 T1 AT E321041T1
- Authority
- AT
- Austria
- Prior art keywords
- alkoxycarbonylamino
- antagonists
- carboxylic acid
- acid derivatives
- heteroaryl carboxylic
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27284901P | 2001-03-02 | 2001-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE321041T1 true ATE321041T1 (de) | 2006-04-15 |
Family
ID=23041569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02722126T ATE321041T1 (de) | 2001-03-02 | 2002-02-25 | Alkoxycarbonylamino-heteroaryl- carbonsäurederivate als ip-antagonisten |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6569860B2 (enExample) |
| EP (1) | EP1368345B1 (enExample) |
| JP (1) | JP2004526721A (enExample) |
| KR (1) | KR100589990B1 (enExample) |
| CN (1) | CN1280289C (enExample) |
| AR (1) | AR033429A1 (enExample) |
| AT (1) | ATE321041T1 (enExample) |
| BR (1) | BR0207730A (enExample) |
| CA (1) | CA2438813C (enExample) |
| DE (1) | DE60210058T2 (enExample) |
| ES (1) | ES2260425T3 (enExample) |
| MX (1) | MXPA03007864A (enExample) |
| WO (1) | WO2002070514A1 (enExample) |
| ZA (1) | ZA200306283B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040054008A1 (en) * | 2002-09-13 | 2004-03-18 | Tohru Araki | Medicament for treatment of nocturia |
| JP2006517576A (ja) * | 2003-02-14 | 2006-07-27 | メディカル リサーチ カウンシル | 病理的子宮症状の治療のためのｉｐレセプターアンタゴニスト |
| US7262313B2 (en) * | 2005-10-20 | 2007-08-28 | Lg Chem, Ltd. | Organic silane compound |
| KR100840114B1 (ko) * | 2005-10-20 | 2008-06-19 | 주식회사 엘지화학 | 점착제 조성물 |
| AR069650A1 (es) * | 2007-12-14 | 2010-02-10 | Actelion Pharmaceuticals Ltd | Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano |
| US9295665B2 (en) | 2013-03-12 | 2016-03-29 | Allergan, Inc. | Inhibition of neovascularization by simultaneous inhibition of prostanoid IP and EP4 receptors |
| WO2014143592A1 (en) | 2013-03-12 | 2014-09-18 | Allergan, Inc. | Inhibition of neovascularization by inhibition of prostanoid ip receptors |
| RS63124B1 (sr) | 2018-03-08 | 2022-05-31 | Incyte Corp | Aminopirazin diol jedinjenja kao pi3k-y inhibitori |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
| EP4119138A1 (en) * | 2021-07-12 | 2023-01-18 | Universität Hamburg | Dhodh inhibitors and their use as antiviral agents |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5908842A (en) | 1995-12-08 | 1999-06-01 | Merck & Co., Inc. | Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase |
| US6184242B1 (en) | 1997-09-04 | 2001-02-06 | Syntex Usa (Llc) | 2-(substituted-phenyl)amino-imidazoline derivatives |
| WO1999026925A1 (en) * | 1997-11-26 | 1999-06-03 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitors comprising heterocyclic amide compounds |
| HUP0104026A3 (en) * | 1998-10-06 | 2002-06-28 | Dainippon Pharmaceutical Co | 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| US6335459B1 (en) * | 1998-12-23 | 2002-01-01 | Syntex (U.S.A.) Llc | Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators |
| HUP0203542A3 (en) * | 1999-08-12 | 2003-07-28 | Upjohn Co | 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same |
| EP1265853A1 (en) * | 2000-03-16 | 2002-12-18 | F. Hoffmann-La Roche AG | Carboxylic acid derivatives as ip antagonists |
-
2002
- 2002-02-25 CA CA002438813A patent/CA2438813C/en not_active Expired - Fee Related
- 2002-02-25 MX MXPA03007864A patent/MXPA03007864A/es active IP Right Grant
- 2002-02-25 DE DE60210058T patent/DE60210058T2/de not_active Expired - Fee Related
- 2002-02-25 CN CNB028058690A patent/CN1280289C/zh not_active Expired - Fee Related
- 2002-02-25 WO PCT/EP2002/001942 patent/WO2002070514A1/en not_active Ceased
- 2002-02-25 AT AT02722126T patent/ATE321041T1/de not_active IP Right Cessation
- 2002-02-25 KR KR1020037011464A patent/KR100589990B1/ko not_active Expired - Fee Related
- 2002-02-25 ES ES02722126T patent/ES2260425T3/es not_active Expired - Lifetime
- 2002-02-25 BR BR0207730-2A patent/BR0207730A/pt not_active IP Right Cessation
- 2002-02-25 JP JP2002569834A patent/JP2004526721A/ja not_active Ceased
- 2002-02-25 EP EP02722126A patent/EP1368345B1/en not_active Expired - Lifetime
- 2002-02-28 AR ARP020100715A patent/AR033429A1/es unknown
- 2002-03-01 US US10/086,615 patent/US6569860B2/en not_active Expired - Fee Related
-
2003
- 2003-08-13 ZA ZA200306283A patent/ZA200306283B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0207730A (pt) | 2004-03-23 |
| ZA200306283B (en) | 2004-11-15 |
| ES2260425T3 (es) | 2006-11-01 |
| CN1280289C (zh) | 2006-10-18 |
| EP1368345A1 (en) | 2003-12-10 |
| AR033429A1 (es) | 2003-12-17 |
| CA2438813A1 (en) | 2002-09-12 |
| MXPA03007864A (es) | 2003-12-04 |
| DE60210058T2 (de) | 2006-11-09 |
| DE60210058D1 (de) | 2006-05-11 |
| WO2002070514A1 (en) | 2002-09-12 |
| US6569860B2 (en) | 2003-05-27 |
| KR100589990B1 (ko) | 2006-06-15 |
| EP1368345B1 (en) | 2006-03-22 |
| US20020169171A1 (en) | 2002-11-14 |
| CA2438813C (en) | 2008-07-29 |
| JP2004526721A (ja) | 2004-09-02 |
| CN1494544A (zh) | 2004-05-05 |
| KR20030078962A (ko) | 2003-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20024387D0 (no) | Karboksylsyrederivater som IP-antagonister | |
| ATE392897T1 (de) | Chinolinderivate als npy antagonisten | |
| NO20041235L (no) | Kinolinderivater som neuropeptid Y antagonister | |
| ATE441631T1 (de) | Phenylpiperidinderivate als serotonin- wiederaufnahmehemmer | |
| ATE461191T1 (de) | N-substituierte 2-oxodihydropyridinderivate als npy antagonisten | |
| DE60110844D1 (de) | Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten | |
| ATE354570T1 (de) | 5,6-diaryl-pyrazineamidderivate als cb1 antagonisten | |
| NO20054957D0 (no) | Subtituerte karboksylsyrer | |
| DE50212761D1 (de) | Neuartige aminodicarbonsäurederivate | |
| NO20032142D0 (no) | Substituerte 2-fenylaminoimidazolin-fenylketon-derivater som IP-antagonister | |
| EE200200490A (et) | Kinoliini derivaadid alfa-2 antagonistidena | |
| DE60118569D1 (de) | 4-phenylpyridin-derivate als neurokinin-1-rezeptor-antagonisten | |
| EE200300447A (et) | Asendatud bensofuraan-2-karboksamiidide derivaadid | |
| DE60218213D1 (de) | Pyridyloxyalkancarbonsäureamid-derivate verwendbar als fungizide | |
| DE60207399D1 (de) | Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten | |
| ATE321041T1 (de) | Alkoxycarbonylamino-heteroaryl- carbonsäurederivate als ip-antagonisten | |
| ATE286018T1 (de) | Biphenylderivate als neurokinin-1 antagonisten | |
| ATE418542T1 (de) | Als ccr5-antagonisten verwendbare aryloxim- piperazine | |
| ATE305001T1 (de) | Propansäure-derivate als integrin-rezeptor- antagonisten | |
| DE50206910D1 (de) | Substituierte y-lactonverbindungen als nmda-antagonisten | |
| ATE280161T1 (de) | Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten | |
| ATE367379T1 (de) | Quinolin-derivate als antientzündungsmittel | |
| ATE382601T1 (de) | Substituierte 4-aminocyclohexanolderivate | |
| NO20042664L (no) | Karboksylsyrederivat | |
| ATE468321T1 (de) | Neue alpha-oxidierte carbonsäure-phenethylamid- derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1368345 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |